KORU Medical Systems Inc KRMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $3.08
- Day Range
- $3.05–3.19
- 52-Week Range
- $2.86–6.61
- Bid/Ask
- $2.95 / $3.60
- Shares Outstanding
- 46.17M
- Market Cap
- $146.36M
- Volume/Avg
- 163,042 / 240,152
Key Statistics
- Price/Earnings (Normalized)
- 607.16
- Price/Sales
- 3.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 73
- Website
- https://www.korumedical.com
Valuation
|
Metric
|
KRMD
|
|---|---|
Price/Earnings (Normalized) | 607.16 |
Price/Book Value | 8.10 |
Price/Sales | 3.25 |
Price/Cash Flow | 72.95 |
Price/Earnings
KRMD
Financial Strength
|
Metric
|
KRMD
|
|---|---|
Quick Ratio | 2.00 |
Current Ratio | 2.72 |
Interest Coverage | — |
Quick Ratio
KRMD
Profitability
|
Metric
|
KRMD
|
|---|---|
Return on Assets (Normalized) | 2.42% |
Return on Equity (Normalized) | 3.92% |
Return on Invested Capital (Normalized) | 2.16% |
Return on Assets
KRMD
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|l&hBRqr | LOCK|sB% | $160B | |||
| Becton Dickinson & Co
BDX
| LOCK|T!h | LOCK|@t!P> | $54B | |||
| ResMed Inc
RMD
| LOCK|c!HK#Y%^ | LOCK|%<qFs | $36B | |||
| Alcon Inc
ALC
| LOCK|gg>>$y | LOCK|VxvW | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|lM&R@v | LOCK|X!D> | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|?D%@vTF@ | LOCK|#m | $28B | |||
| Solventum Corp
SOLV
| LOCK|NZ@!LV# | LOCK|#C | $15B | |||
| Baxter International Inc
BAX
| LOCK|C< | LOCK|%F&gg | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|MFC%%p | LOCK|jDR#? | $12B | |||
| Repligen Corp
RGEN
| LOCK|G@<%nmyk | LOCK|s?># | $11B |
United States